Item Type | Name |
Academic Article
|
Lack of a functional alternative complement pathway ameliorates ischemic acute renal failure in mice.
|
Academic Article
|
A novel inhibitor of the alternative complement pathway prevents antiphospholipid antibody-induced pregnancy loss in mice.
|
Academic Article
|
Altered renal tubular expression of the complement inhibitor Crry permits complement activation after ischemia/reperfusion.
|
Academic Article
|
Pharmacological complement inhibition at the C3 convertase level promotes neuronal survival, neuroprotective intracerebral gene expression, and neurological outcome after traumatic brain injury.
|
Academic Article
|
Factor B of the alternative complement pathway regulates development of airway hyperresponsiveness and inflammation.
|
Academic Article
|
Treatment with an inhibitory monoclonal antibody to mouse factor B protects mice from induction of apoptosis and renal ischemia/reperfusion injury.
|
Academic Article
|
Alternative complement pathway activation is essential for inflammation and joint destruction in the passive transfer model of collagen-induced arthritis.
|
Academic Article
|
Candidate inhibitors of porcine complement.
|
Academic Article
|
The alternative pathway of complement activation is critical for blister induction in experimental epidermolysis bullosa acquisita.
|
Academic Article
|
New approaches to the treatment of dense deposit disease.
|
Academic Article
|
Evidence for non-traditional activation of complement factor C3 during murine liver regeneration.
|
Academic Article
|
Alternative pathway of complement in children with diarrhea-associated hemolytic uremic syndrome.
|
Academic Article
|
Enhanced susceptibility to acute pneumococcal otitis media in mice deficient in complement C1qa, factor B, and factor B/C2.
|
Academic Article
|
Renal inflammation: targeted iron oxide nanoparticles for molecular MR imaging in mice.
|
Academic Article
|
Aseptic injury to epithelial cells alters cell surface complement regulation in a tissue specific fashion.
|
Academic Article
|
An allelic variant of Crry in the murine Sle1c lupus susceptibility interval is not impaired in its ability to regulate complement activation.
|
Academic Article
|
The complement inhibitors Crry and factor H are critical for preventing autologous complement activation on renal tubular epithelial cells.
|
Academic Article
|
Dynamic control of the complement system by modulated expression of regulatory proteins.
|
Academic Article
|
Essential role of factor B of the alternative complement pathway in complement activation and opsonophagocytosis during acute pneumococcal otitis media in mice.
|
Academic Article
|
Binding of factor H to tubular epithelial cells limits interstitial complement activation in ischemic injury.
|
Academic Article
|
Detection of glomerular complement C3 fragments by magnetic resonance imaging in murine lupus nephritis.
|
Academic Article
|
Identification of a central role for complement in osteoarthritis.
|
Academic Article
|
Sublytic membrane-attack-complex activation and VEGF secretion in retinal pigment epithelial cells.
|
Academic Article
|
Factor friction: protective and pathogenic roles for complement factors in immune complex glomerulonephritis.
|
Academic Article
|
Noninvasive detection of complement activation through radiologic imaging.
|
Academic Article
|
IgM contributes to glomerular injury in FSGS.
|
Academic Article
|
The central role of the alternative complement pathway in human disease.
|
Academic Article
|
Reduced neuronal cell death after experimental brain injury in mice lacking a functional alternative pathway of complement activation.
|
Academic Article
|
Complement activation induces dysregulation of angiogenic factors and causes fetal rejection and growth restriction.
|
Academic Article
|
Complement C5a receptors and neutrophils mediate fetal injury in the antiphospholipid syndrome.
|
Academic Article
|
The alternative pathway of complement in disease: opportunities for therapeutic targeting.
|
Academic Article
|
Acute tubular necrosis is characterized by activation of the alternative pathway of complement.
|
Academic Article
|
The alternative pathway of complement is activated in the glomeruli and tubulointerstitium of mice with adriamycin nephropathy.
|
Academic Article
|
Binding of avian IgY to type VII collagen does not activate complement and leucocytes and fails to induce subepidermal blistering in mice.
|
Academic Article
|
Ca2+/calmodulin-dependent kinase II triggers cell membrane injury by inducing complement factor B gene expression in the mouse heart.
|
Academic Article
|
C3a is required for the production of CXC chemokines by tubular epithelial cells after renal ishemia/reperfusion.
|
Academic Article
|
Oxidative stress renders retinal pigment epithelial cells susceptible to complement-mediated injury.
|
Academic Article
|
Inhibition of the alternative complement activation pathway in traumatic brain injury by a monoclonal anti-factor B antibody: a randomized placebo-controlled study in mice.
|
Academic Article
|
Targeted inhibition of the complement alternative pathway with complement receptor 2 and factor H attenuates collagen antibody-induced arthritis in mice.
|
Academic Article
|
A targeted inhibitor of the complement alternative pathway reduces RPE injury and angiogenesis in models of age-related macular degeneration.
|
Academic Article
|
B cell subsets contribute to renal injury and renal protection after ischemia/reperfusion.
|
Academic Article
|
Delineation of the complement receptor type 2-C3d complex by site-directed mutagenesis and molecular docking.
|
Academic Article
|
IgG autoantibodies against deposited C3 inhibit macrophage-mediated apoptotic cell engulfment in systemic autoimmunity.
|
Academic Article
|
The critical role of complement alternative pathway regulator factor H in allergen-induced airway hyperresponsiveness and inflammation.
|
Academic Article
|
Complement alternative pathway activation in the autologous phase of nephrotoxic serum nephritis.
|
Academic Article
|
Complement activation and toll-like receptor-2 signaling contribute to cytokine production after renal ischemia/reperfusion.
|
Academic Article
|
Role of the alternative and classical complement activation pathway in complement mediated killing against Streptococcus pneumoniae colony opacity variants during acute pneumococcal otitis media in mice.
|
Academic Article
|
Therapeutic inhibition of the alternative complement pathway attenuates chronic EAE.
|
Academic Article
|
Detection of complement activation using monoclonal antibodies against C3d.
|
Concept
|
Complement Inactivating Agents
|
Concept
|
Complement C4
|
Concept
|
Receptors, Complement 3b
|
Concept
|
Complement C5a
|
Concept
|
Complement C3b Inactivator Proteins
|
Concept
|
Complement C4a
|
Concept
|
Complement Membrane Attack Complex
|
Concept
|
Complement C4b-Binding Protein
|
Concept
|
Complement C2
|
Concept
|
Complement C9
|
Concept
|
Complement Factor B
|
Concept
|
Complement C3-C5 Convertases
|
Concept
|
Complement C3b
|
Concept
|
Complement Pathway, Classical
|
Concept
|
Complement Pathway, Mannose-Binding Lectin
|
Concept
|
Complement C3a
|
Concept
|
Complement Activation
|
Concept
|
Complement Pathway, Alternative
|
Concept
|
Complement C1q
|
Concept
|
Complement Factor D
|
Concept
|
Complement Factor H
|
Concept
|
Complement C5b
|
Concept
|
Receptors, Complement 3d
|
Concept
|
Complement Inactivator Proteins
|
Concept
|
Complement C5
|
Concept
|
Complement C3
|
Concept
|
Complement C6
|
Concept
|
Complement System Proteins
|
Concept
|
Receptors, Complement
|
Concept
|
Complement Fixation Tests
|
Concept
|
Complement C3d
|
Academic Article
|
A zebrafish model for uremic toxicity: role of the complement pathway.
|
Academic Article
|
Cyclosporine induces endothelial cell release of complement-activating microparticles.
|
Academic Article
|
Complement factor B is the downstream effector of TLRs and plays an important role in a mouse model of severe sepsis.
|
Academic Article
|
The role of the complement system in acute kidney injury.
|
Academic Article
|
C3 glomerulopathy: consensus report.
|
Academic Article
|
New anti-complement drugs: not so far away.
|
Academic Article
|
Deletion of the complement C5a receptor alleviates the severity of acute pneumococcal otitis media following influenza A virus infection in mice.
|
Academic Article
|
Shiga toxin promotes podocyte injury in experimental hemolytic uremic syndrome via activation of the alternative pathway of complement.
|
Academic Article
|
Complement in kidney disease: core curriculum 2015.
|
Academic Article
|
The alternative complement component factor B regulates UV-induced oedema, systemic suppression of contact and delayed hypersensitivity, and mast cell infiltration into the skin.
|
Academic Article
|
Complement inhibition prevents oncolytic vaccinia virus neutralization in immune humans and cynomolgus macaques.
|
Academic Article
|
IgM exacerbates glomerular disease progression in complement-induced glomerulopathy.
|
Academic Article
|
Complement Activation in Patients with Focal Segmental Glomerulosclerosis.
|
Academic Article
|
The Complement System and Antibody-Mediated Transplant Rejection.
|
Academic Article
|
Annexin A2 Enhances Complement Activation by Inhibiting Factor H.
|
Academic Article
|
Complement Factor B Production in Renal Tubular Cells and Its Role in Sodium Transporter Expression During Polymicrobial Sepsis.
|
Academic Article
|
Properdin-Mediated C5a Production Enhances Stable Binding of Platelets to Granulocytes in Human Whole Blood.
|
Academic Article
|
Distinct roles for the complement regulators factor H and Crry in protection of the kidney from injury.
|
Academic Article
|
New therapeutic and diagnostic opportunities for injured tissue-specific targeting of complement inhibitors and imaging modalities.
|
Academic Article
|
Never make assumptions: the?complicated role of complement in urinary tract?infections.
|
Academic Article
|
Targeting the complement cascade: novel treatments coming down the pike.
|
Academic Article
|
All Things Complement.
|
Academic Article
|
Mapping the Complement Factor H-Related Protein 1 (CFHR1):C3b/C3d Interactions.
|
Academic Article
|
Getting over our Immune-Complex - C5a receptor blockade is the answer.
|
Academic Article
|
Complement Alternative Pathway Deficiency in Recipients Protects Kidney Allograft From Ischemia/Reperfusion Injury and Alloreactive T Cell Response.
|
Academic Article
|
Many drugs for many targets: novel treatments for complement-mediated glomerular disease.
|
Grant
|
Complement and Ischemic Acute Renal Failure
|
Grant
|
Complement Activation and Renal Ischemia/Reperfusion Injury
|
Grant
|
Complement-mediated injury of the kidney: New mechanisms and novel therapies
|
Academic Article
|
The Evolving Landscape for Complement Therapeutics in Rheumatic and Autoimmune Diseases.
|
Grant
|
Immunologic Mechanisms of Progressive Glomerulosclerosis
|
Academic Article
|
Complement factor H-related proteins in IgA nephropathy-sometimes a gentle nudge does the trick.
|
Academic Article
|
Complement Activation via a C3a Receptor Pathway Alters CD4+ T Lymphocytes and Mediates Lung Cancer Progression.
|
Academic Article
|
Modulation of the Alternative Pathway of Complement by Murine Factor H-Related Proteins.
|
Academic Article
|
Complement factor H protects mice from ischemic acute kidney injury but is not critical for controlling complement activation by glomerular IgM.
|
Academic Article
|
The relationship between complement C3 expression and the MUC5B genotype in pulmonary fibrosis.
|
Academic Article
|
Specific Inhibition of Complement Activation Significantly Ameliorates Autoimmune Blistering Disease in Mice.
|
Academic Article
|
SPECT/CT Imaging of Mycobacterium tuberculosis Infection with [125I]anti-C3d mAb.
|
Academic Article
|
Alternative Pathway Is Essential for Glomerular Complement Activation and Proteinuria in a Mouse Model of Membranous Nephropathy.
|
Academic Article
|
Endothelial Microparticles and Systemic Complement Activation in Patients With Chronic Kidney Disease.
|
Academic Article
|
Tissue-targeted complement therapeutics.
|
Academic Article
|
Complement Biomarkers of Hemolytic Uremic Syndrome-If Not One Thing, Maybe Another.
|
Grant
|
Effects of Complement on the Tumor Microenvironment in Lung Cancer
|
Academic Article
|
Complement Therapeutics in Autoimmune Disease.
|
Academic Article
|
The role of complement in antibody mediated transplant rejection.
|
Academic Article
|
Urine complement activation fragments are increased in patients with kidney injury after cardiac surgery.
|
Academic Article
|
Immunoglobulin-driven Complement Activation Regulates Proinflammatory Remodeling in Pulmonary Hypertension.
|
Academic Article
|
The Role of Complement in Organ Transplantation.
|
Academic Article
|
Targeting the Immune Complex-Bound Complement C3d Ligand as a Novel Therapy for Lupus.
|
Academic Article
|
Complement fragments are biomarkers of antibody-mediated endothelial injury.
|
Academic Article
|
Complement factor H-deficient mice develop spontaneous hepatic tumors.
|
Academic Article
|
Inflammation, immunity, and vascular remodeling in pulmonary hypertension; Evidence for complement involvement?
|
Academic Article
|
Complement and the Kidney: An Overview.
|
Academic Article
|
Loss of decay-accelerating factor triggers podocyte injury and glomerulosclerosis.
|
Academic Article
|
Properdin Is a Key Player in Lysis of Red Blood Cells and Complement Activation on Endothelial Cells in Hemolytic Anemias Caused by Complement Dysregulation.
|
Academic Article
|
Complement-mediated kidney diseases.
|
Academic Article
|
Complement and Cancer-A Dysfunctional Relationship?
|
Academic Article
|
Rhabdomyolysis and complement-once again, epithelial cells take center stage.
|
Academic Article
|
Complement Detection in Mouse Kidneys by Immunofluorescence.
|
Academic Article
|
A clinical approach to children with C3 glomerulopathy.
|
Academic Article
|
Mechanisms of SARS-CoV-2-induced lung vascular disease: potential role of complement.
|
Academic Article
|
Natural antibody and complement activation characterize patients with idiopathic nephrotic syndrome.
|
Academic Article
|
Improving Clinical Trials for Anticomplement Therapies in Complement-Mediated Glomerulopathies: Report of a Scientific Workshop Sponsored by the National Kidney Foundation.
|
Academic Article
|
Marginal zone B cells acquire dendritic cell functions by trogocytosis.
|
Academic Article
|
Complement Activation Fragments Are Increased in Critically Ill Pediatric Patients with Severe AKI.
|
Academic Article
|
Development and Optimization of Bifunctional Fusion Proteins to Locally Modulate Complement Activation in Diseased Tissue.
|
Academic Article
|
The complement system in pediatric acute kidney injury.
|
Academic Article
|
Factor H related proteins modulate complement activation on kidney cells.
|
Academic Article
|
The susceptibility of the kidney to alternative pathway activation-A hypothesis.
|
Academic Article
|
Alternative pathway diagnostics.
|
Academic Article
|
The complement alternative pathway in health and disease-activation or amplification?
|
Academic Article
|
Upregulation of complement proteins in lung cancer cells mediates tumor progression.
|
Academic Article
|
Urine Complement Factor Ba Is Associated with AKI in Critically Ill Children.
|
Academic Article
|
Noninvasive Detection of iC3b/C3d Deposits in the Kidney Using a Novel Bioluminescent Imaging Probe.
|
Academic Article
|
MOGAD patient autoantibodies induce complement, phagocytosis, and cellular cytotoxicity.
|
Academic Article
|
Complement inhibitors in pediatric kidney diseases: new therapeutic opportunities.
|
Academic Article
|
The role of complement in kidney disease.
|
Grant
|
The Alternative Pathway of Complement: A Potential Contributor to Adverse Outcomes in CKD
|